The analysis by Manuel and colleagues creates controversy with headlines, not data

CMAJ. 2005 Apr 12;172(8):1033-4; discussion 1037. doi: 10.1503/cmaj.1041427.
No abstract available

Publication types

  • Comment

MeSH terms

  • Canada
  • Cholesterol, LDL / blood
  • Coronary Disease / mortality
  • Coronary Disease / prevention & control*
  • Health Expenditures
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use
  • Practice Guidelines as Topic*
  • Risk Factors

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents